Inhibitory effects against Trypanosoma cruzi, Leishmania infantum and trypanothione reductase of N1,N4-bisbenzylbutane-1,4-diamines

Read full text
Authors: Otília Höeller Guarnieri, Mariza Gabriela Faleiro de Moura Lodi Cruz, Daniela de Melo Resende, Carime Lessa Mansur Pontes, Igor Vivan Roberto, Luiza Schmidt D'Agostini, Bertha Chithambo, Niklas Ehlenz, Xavier Siwe‐Noundou, Rui W. M. Krause, Maique W. Biavatti, Jaya Lakkakula
+5 more Nilesh Shirish Wagh, Mário Steindel, Till Opatz, Silvane Maria Fonseca Murta, Louis P. Sandjo
Cited by: 0
References: 12

Abstract

Trypanosoma cruzi and Leishmania spp. are the protozoan parasites responsible for Chagas disease and leishmaniasis. The treatment of these neglected diseases relies on repurposed drugs and faces several challenges including high toxicity, and the emergence of resistant strain. Therefore, there is a constant demand for promising antiparasitic agents. The present work aimed to investigate seventeen prepared N 1 , N 4 -bisbenzylbutane-1,4-diamines against recombinant T. cruzi and L. infantum as well as their inhibitory effects against the T. cruzi recombinant trypanothione reductase (TcTR). N 1 , N 4 -bis(4-chlorobenzyl)butane-1,4-diamine showed significant trypanocidal activity with an IC 50 of 6.0 ± 0.9 μM with a selectivity index of 4.3. This compound was more active than the positive control, benznidazole (IC 50 of 14.6). It moderately inhibited TcTR with an IC 50 of 55.6 ± 18.6 μM. N 1 , N 4 -bis(4-chlorobenzyl)butane-1,4-diamine also inhibited L. infantum with an IC 50 of 19.3 ± 1.2 μM (SI of 3.4). N 1 , N 4 -bis(( E )-3-(2-methoxyphenyl)allyl)butane-1,4-diamine exhibited potent inhibitory effect against T. cruzi (2.4 ± 0.3 μM); However, it also turned out to be highly cytotoxic to the L929 fibroblast cell line. Its inhibitory effect against TcTR was also significant, with an IC 50 of 3.9 ± 1.9 μM. Alongside the two diamines, nine other synthesized derivatives displayed antitrypanosomal activity with IC 50 ranging from 8 to 150 μM. Concerning the leishmanicidal effects, all tested compounds were moderately active. Moreover, during in silico studies of the active compounds using TcTR (PDB ID 4NEW ), N 1 , N 4 -bis(( E )-3-(2-methoxyphenyl)allyl)butane-1,4-diamine emerged as the most promising candidate, displaying both strong binding affinity and significant biological activity. • Reductive amination led to seventeen N 1 , N 4 -bisbenzylbutane-1,4-diamines. • N 1 , N 4 -bis(4-chlorobenzyl)butane-1,4-diamine showed significant trypanocidal effect. • N 1 , N 4 -bis(( E )-3-(2-methoxyphenyl)allyl)butane-1,4-diamine was strongly anti- T. cruzi. • The anti -T. cruzi activity was related to the trypanothione reductase inhibition.

Fields of Study & Subjects

Trypanosoma species research and implications Research on Leishmaniasis Studies Synthesis and Characterization of Heterocyclic Compounds

Publication details

Journal / source
Bioorganic & Medicinal Chemistry Letters
Volume
134
Pages
130541–130541
Publication date
13 January 2026
Language
EN